Evidence-based review: Quality of life following head and neck intensity-modulated radiotherapy

被引:44
作者
Scott-Brown, Martin [2 ]
Miah, Aisha [1 ]
Harrington, Kevin [1 ,3 ]
Nutting, Chris [1 ]
机构
[1] Royal Marsden Hosp, Head & Neck Unit, London SW3 6JJ, England
[2] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford OX1 2JD, England
[3] Inst Canc Res, London SW3 6JB, England
关键词
Head and neck cancer; Intensity-modulated radiotherapy; Quality of life; STAGE NASOPHARYNGEAL CARCINOMA; PAROTID-GLAND FUNCTION; CANCER RECEIVING RADIOTHERAPY; CONVENTIONAL RADIOTHERAPY; RADIATION-THERAPY; CONFORMAL RADIOTHERAPY; SALIVARY FUNCTION; INITIAL REPORT; XEROSTOMIA; IMRT;
D O I
10.1016/j.radonc.2010.08.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Inverse planned Intensity modulated radiotherapy (IMRT) can minimize the dose to normal structures and therefore can reduce long-term radiotherapy-related morbidity and may improve patients' long-term quality of life. Despite overwhelming evidence that IMRT can reduce late functional deficits in patients with head and neck cancer, treated with radiotherapy, a review of the published literature production conflicting results with regard to quality of life outcomes. Following a critical appraisal of the literature, reasons for the discrepant outcomes are proposed. (C) 2010 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 97 (2010) 249-257
引用
收藏
页码:249 / 257
页数:9
相关论文
共 51 条
[1]   Quality of life and head and neck cancer: A 5 year prospective study [J].
Abendstein, H ;
Nordgren, M ;
Boysen, M ;
Jannert, M ;
Silander, E ;
Ahlner-Elmqvist, M ;
Hammerlid, E ;
Bjordal, K .
LARYNGOSCOPE, 2005, 115 (12) :2183-2192
[2]   A prospective study of quality of life in head and neck cancer patients.: Part II:: Longitudinal data [J].
Bjordal, K ;
Ahlner-Elmqvist, M ;
Hammerlid, E ;
Boysen, M ;
Evensen, JF ;
Biörklund, A ;
Jannert, M ;
Westin, T ;
Kaasa, S .
LARYNGOSCOPE, 2001, 111 (08) :1440-1452
[3]   Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy [J].
Blanco, AI ;
Chao, KSC ;
El Naqa, I ;
Franklin, GE ;
Zakarian, K ;
Vicic, M ;
Deasy, JO .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (04) :1055-1069
[4]   Quality of life and salivary output in patients with head-and-neck cancer five years after radiotherapy [J].
Braam, Petra M. ;
Roesink, Judith M. ;
Raaijmakers, Cornelis P. J. ;
Busschers, Wim B. ;
Terhaard, Chris H. J. .
RADIATION ONCOLOGY, 2007, 2
[5]   Long-term parotid gland function after radiotherapy [J].
Braam, PM ;
Roesink, JM ;
Moerland, MA ;
Raaijmakers, CPJ ;
Schipper, M ;
Terhaard, CHJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (03) :659-664
[6]   Dose-response relationships within the parotid gland after radiotherapy for head and neck cancer [J].
Bussels, B ;
Maes, A ;
Flamen, P ;
Lambin, P ;
Erven, K ;
Hermans, R ;
Nuyts, S ;
Weltens, C ;
Cecere, S ;
Lesaffre, E ;
Van den Bogaert, W .
RADIOTHERAPY AND ONCOLOGY, 2004, 73 (03) :297-306
[7]   Intensity-modulated radiation therapy: Supportive data for prostate cancer [J].
Cahlon, Oren ;
Hunt, Margie ;
Zelefsky, Michael J. .
SEMINARS IN RADIATION ONCOLOGY, 2008, 18 (01) :48-57
[8]   A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results [J].
Chao, KSC ;
Deasy, JO ;
Markman, J ;
Haynie, J ;
Perez, CA ;
Purdy, JA ;
Low, DA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 49 (04) :907-916
[9]   LARGE COHORT DOSE-VOLUME RESPONSE ANALYSIS OF PAROTID GLAND FUNCTION AFTER RADIOTHERAPY: INTENSITY-MODULATED VERSUS CONVENTIONAL RADIOTHERAPY [J].
Dijkema, Tim ;
Terhaard, Chris H. J. ;
Roesink, Judith M. ;
Braam, Petra M. ;
van Gils, Carla H. ;
Moerland, Marinus A. ;
Raaijmakers, Cornelis P. J. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (04) :1101-1109
[10]   Intensity-modulated radiation therapy in the treatment of head and neck cancer [J].
Eisbruch, A .
NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (01) :34-39